Investments of 3 billion Swiss francs in modern research infrastructure, attractive workplaces and sustainable site development Basel, 22 October 2014 – Today Roche presented development plans for its Basel site. Over the next 10 years, Roche will invest 3 billion Swiss francs in the construction of a new research and development centre for around 1,900 employees, […]

Paris, France – 20 October 2014 – GE Healthcare has been chosen by the Medical Imaging Antilles-Guyane (IMAG) purchasing group in France to lead a consortium providing a new cloud imaging platform which will allow vastly improved collaboration between clinicians in Martinique, Guadeloupe and French Guyana. The clinicians will be able to share diagnostic images […]

Biologics License Application (BLA) for secukinumab, a “first-in-class” IL-17A inhibitor, is currently under FDA review with an anticipated action date in early 2015 FDA Advisory Committee recommendation based on efficacy and safety outcomes of 10 Phase II/III clinical studies of secukinumab in moderate-to-severe plaque psoriasis Affecting 7.5 million Americans, psoriasis may negatively impact daily life […]

Phase III clinical study data presented at IDWeek in Philadelphia October 20, 2014 – WHITEHOUSE STATION, N.J. & SWIFTWATER, Pa.–(BUSINESS WIRE)–Merck (NYSE:MRK), known as MSD outside the United States and Canada, and Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT:SAN and NYSE:SNY), announced today that the Biologics License Application (BLA) filed for the companies’ investigational […]

The new care pathway for advanced pelvic cancer encourages knowledge transfer and multidisciplinary care Stockholm, Sweden – 17 October 2014 – GE Healthcare and Karolinska University Hospital in Stockholm, Sweden, have established a partnership to improve the efficiency of the care pathway for pelvic cancer patients and reduce unwarranted clinical variation. GE Healthcare will be […]

Approximately 100,000 people in the United States have IPF, an irreversible and fatal lung disease1 Esbriet approved under FDA’s breakthrough designation program Basel, 16 October 2014 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the U.S. Food and Drug Administration (FDA) has approved Esbriet (pirfenidone) as a treatment for idiopathic pulmonary fibrosis (IPF) […]

Low Level of Awareness Revealed About Breast Density and Lower Accuracy of Mammogram Screening for Dense Breasts NEW YORK, NY, October 8, 2014–A new survey entitled “Diagnosis Anxiety: The Working Mother Breast Screening Report” sheds important new information on the level of awareness women have about breast cancer today and what they are doing to […]

CHALFONT ST GILES, UK – 3 October 2014 – GE Healthcare Life Sciences (NYSE:GE) announced today that the company has been shortlisted as a finalist for four BioProcess International (BPI) Awards1. These prestigious awards, which are voted for by experts in the field and supported by bioprocess specialist publication BioProcess International – celebrate and recognize […]